SEARCH
Quotes News NAV
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
ERIS Lifesciences Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540596 INE406M01024 184.651184 ERIS 0.41 24,382.73 315.18 5.68 1
ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.600.080.000.000.07
Long Term Debt-Equity Ratio0.150.050.000.000.00
Current Ratio1.152.542.862.731.84
Fixed Assets1.051.431.631.571.64
Inventory19.6818.0516.2517.0214.56
Debtors6.517.319.678.719.42
Interest Cover Ratio6.7322.00151.34414.72165.26
PBIDTM (%)31.9738.9742.2038.5536.31
PBITM (%)25.2734.1537.9735.1631.91
PBDTM (%)28.2237.4241.9538.4736.12
CPM (%)26.3134.5238.5535.0132.95
APATM (%)19.6129.6934.3231.6228.55
ROCE (%)9.9819.9425.6826.4824.21
RONW (%)12.6319.2323.8824.3923.72